.Atea Pharmaceuticals' antiviral has stopped working one more COVID-19 trial, yet the biotech still ...
.Neurocrine Biosciences' schizophrenia program pivot has stopped working. The biotech was actually n...
.Sanofi has created an overdue entry to the radioligand party, spending 100 thousand euros ($ 110 mi...
.After F2G's first try to receive a new training class of antifungal to market was hindered by the F...
.Moderna has promised to cut R&D investing through $1.1 billion by 2027. The selection to retract...
.Only four months after Sanofi bet $80 million in ahead of time cash on Key Therapies' losmapimod, t...
.Cancer cells business Oncternal Therapies is actually folding all its scientific trials and giving ...
.Roche is actually storing out chances that its own injectable excessive weight prospect might at so...
.Novo Nordisk has actually lifted the top on a phase 1 trial of its oral amylin and GLP-1 receptor c...
.Merely a couple of brief full weeks after succeeding an FDA Fast Track tag for its investigational ...